View more articles


Sino Biological

SARS-CoV-2 Detection Antigens and Antibodies

To support the studies on the development of rapid diagnostic tools, vaccines and therapeutic antibodies for COVID-19, Sino Biological has developed a comprehensive panel of research reagents for the Novel Coronavirus SARS-CoV-2, including Recombinant Antigens (N protein, S protein, S1 and S2 subunits of S protein, and RBD domain of S protein), Monoclonal Antibodies, and Antigen Detection Kits.

Click for more information


TS5A: Your NGS Lab: Relevant Issues from Test Development to Commercialization

Nearly 10 years after the first publication of next-generation sequencing, this paradigm shifting technology has progressively migrated into the clinical diagnostic space. A diversity of clinical diagnostic assays is now routinely performed on a variety of NGS platforms, spanning from single gene to multi-gene sequencing, to genome wide analyses for the detection of germline and somatic mutations. For clinical laboratories with NGS experience, and especially for those just starting to use the technology, designing and operationalizing robust NGS assays remains a challenge. This training seminar will review principles and diagnostic approaches for NGS assays as applied to molecular oncology and inherited disorders, platforms and instruments, as well as laboratory accreditation and proficiency testing specific to NGS.

Click here for more information